Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4‐week, open‐label clinical study

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 10, 2015-10 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

By Prasad Suyash   Harpin Val   Poole Lynne   Zeitlin Harry   Jamdar Saroj   Puvanendran Kanagasabai    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 379-394

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label Pilot Study of Homeopathic Treatment of Attention Deficit Hyperactivity Disorder in Children and Youth

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 21, Iss. 5, 2014-09 ,pp. : 302-309

Karger

Access to resources Recommend Favorite

Risk of subsequent attention‐deficit/hyperactivity disorder among children and adolescents with amalgam restorations: A nationwide longitudinal study

By  

COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, Vol. 46, Iss. 1, 2018-02 ,pp. : 47-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

Attention deficit hyperactivity disorder (ADHD) in children and adolescents

By  

PROGRESS IN NEUROLOGY AND PSYCHIATRY, Vol. 19, Iss. 3, 2015-05 ,pp. : 16-23

John Wiley & Sons Inc

Access to resources Recommend Favorite